New strategic plan for NIH obesity research seeks to curb epidemic

By Bouvier Grant Group

We stay current on NIH happenings and would be delighted to keep you informed.

Today the NIH announced the release of its new strategic plan to combat obesity. The Task Force that developed the recommendations was composed of researchers, health care professionals, and the public and was chaired by the Directors of NHLBI, NIDDK, NICHD, and NCI.

Task Force recommendations include prioritizing research to:

· discover key processes that regulate body weight and influence behavior

· understand the factors that contribute to obesity and its consequences

· design and test new approaches for achieving and maintaining a healthy weight

· evaluate promising strategies to prevent and treat obesity in real-world settings and diverse populations

· use technology to advance obesity research and improve healthcare delivery

NIH’s first strategic plan for obesity was released in 2004 under Elias Zerhouni. In FY2010, NIH spent $824M on research to reduce the prevalence of obesity and its health consequences. Look for that funding level to continue even with budget cuts looming on the horizon, as NIH continues to commit itself to what is arguably the number one public health crisis in the country. One-third of adults in the US and 17% of children are obese. The most prevalent, deadly, and costly diseases in the US—heart disease, type II diabetes, and many cancers—are directly related to obesity.

This topic is near and dear to my heart (I trained as a ballet dancer, have been a runner for years, and am writing this blog upon returning from a Pilates class.) By choice, many of my grant and policy clients are exercise physiologists and I have a satisfying, ongoing business association with the American College of Sports Medicine, an organization for which I have a great deal of respect. I am delighted to see NIH reaffirm its commitment to this troubling area.

Author:
Dr. Meg Bouvier

Margaret Bouvier received her PhD in 1995 in Biomedical Sciences from the Mount Sinai School of Medicine. After an NINDS post-doctoral fellowship, she worked as a staff writer for long-standing NIH Director Dr. Francis Collins in the Office of Press, Policy, and Communications for the Human Genome Project and NHGRI. Since 2007, Meg has specialized in editing and advising on NIH submissions, and began offering virtual courses in 2015. She's recently worked with more than 40% of the nation's highest-performing hospitals*, four of the top 10 cancer hospitals, three of the top five medical schools for research, and 14 NCI-designated cancer centers. Her experience at NIH as both a bench scientist and staff writer greatly informs her approach to NIH grantwriting. She has helped clients land over half a billion in federal funding. Bouvier Grant Group is a woman-owned small business.

*Our clients include 9 of the top 22 hospitals as recognized by the 2023/24 US News & World Report honor roll

Categories:
We read all NIH notices for our clients. When you join our mailing list, we’ll pass along important changes directly to your inbox, as well as opportunities to improve your grantsmanship skills.
Primary Position
Lead Source

Wait!

Subscribe to our monthly newsletter for the latest NIH news, grantwriting tips, and more.

NIH-October-2023-Newsletter